| advertise add site services publishers database health videos | ![]() | about toolbar stats live show health store more stuff JOIN/LOGIN |
Butylated hydroxyanisole: Carcinogenic Potency Database potency.berkeley.edu |
Butylated hydroxyanisole (BHA) is an antioxidant consisting of a mixture of two isomeric organic compounds, 2-tert-butyl-4-hydroxyanisole and 3-tert-butyl-4-hydroxyanisole. It is prepared from 4-methoxyphenol and isobutylene. It is a waxy solid used in certain amounts as a food additive with the E number E320. Some controversy surrounds the use of BHA as an antioxidant. However, the acceptable daily intake (ADI) of BHA and a similar preservative, butylated hydroxytoluene BHT, is exceeded by only a small fraction of the population [3]. Furthermore, the usual low intake levels of BHA and BHT showed no significant association with an increased risk of cancer[4]. Like butylated hydroxytoluene (BHT), the conjugated aromatic ring of BHA is able to stabilize free radicals, sequestering them. By acting as free radical scavengers, further free radical reactions are prevented. BHA is also commonly used in medicines, such as isotretinoin (known as Accutane/Roaccutane), lovastatin, and simvastatin, among others. [edit] See also[edit] References
| ||||||||||||||||||||||||||||||||||
| ↑ top of page ↑ | about thumbshots |